Trastuzumab deruxtecan, arrivano conferme da San Antonio
[Oncoinfo – Oncology Snapshots: follow us on http://oncoinfo.it] Trastuzumab deruxtecan continues to be a hot topic at the 2021 San Antonio Breast Cancer Symposium. What's the latest on the use of this monoclonal antibody drug conjugate (ADC) in patients with HER2-positive breast cancer? We asked Claudio Zamagni, Director of Addarii Breast and Gynecological Medical Oncology – IRCCS Policlinico Sant’Orsola, Bologna.
▶︎
Metastatic HER2+ breast cancer, trastuzumab deruxtecan reduces risk of death by more than a third
▶︎
Tumori gastrici: ottimizzare efficacia e tollerabilità di trastuzumab deruxtecan
▶︎
Breast cancer: the revolution of trastuzumab deruxtecan
▶︎
Trastuzumab-pertuzumab subcutaneous formulation arrives in Italy for HER2+ breast cancer
▶︎
BREAST CANCER: AIFA APPROVES TRASTUZUMAB DERUXTECAN FOR HER2-LOW METASTATIC DISEASE
▶︎
How Long Chemo Side Effects Really Last?
▶︎
She’s 12. She Sings Aretha Franklin… Until Simon TELLS Her to Do It Acapella! 😳
▶︎
Trastuzumab-Deruxtecan modulates HER2+ breast cancer cell fate and immune microenvironment
▶︎
Chemioterapia - Effetti Collaterali: Come Prevenirli e Combatterli
▶︎
Chemo Port: Things You Want to Know… But Didn’t Ask
▶︎
Metastatic HER2-low Breast Cancer: A Revolution with Trastuzumab Deruxtecan
▶︎
T-DXd nei diversi setting del tumore della mammella: efficacia e ottimizzazione del trattamento
▶︎
Tumore al seno HER2+ metastatico, con trastuzumab deruxtecan rischio di progressione ridotto del 72%
▶︎
Even kids will love eggplants with this delicious recipe! Easy and cheap eggplant recipe!
▶︎
What You Actually Need to Know About NAC and Cancer
▶︎
Use These 5 Food Hacks To Heal The Body & STARVE CANCER I Dr. William Li
▶︎
Perchè Trastuzumab deruxtecan ha vinto il Prix Galien 2024
▶︎
She Wasn't Even Done Singing Yet When The GOLD Confetti Filled The Stage! 🤩
▶︎
The fight against cancer with cancer immunotherapy: Dr. Michele Maio presents the CIO in Siena
▶︎